Dr. Tsibris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Grj 504
Boston, MA 02114Phone+1 617-726-3812Fax+1 617-726-7416
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2002 - 2006
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1998 - 2002
- University of South Florida College of MedicineClass of 1998
Certifications & Licensure
- MA State Medical License 2004 - 2025
- IL State Medical License 1998 - 2002
Clinical Trials
- Pharmacokinetics and Safety of SAR441236 Start of enrollment: 2019 May 20
Publications & Presentations
PubMed
- HIV-1 latency reversal agent boosting is not limited by opioid use.Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche
JCI Insight. 2024-11-22 - HIV-1 latency reversal agent boosting is not limited by opioid use.Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche
Medrxiv. 2024-06-04 - 8 citationsViral and host mediators of non-suppressible HIV-1 viremia.Abbas Mohammadi, Behzad Etemad, Xin Zhang, Yijia Li, Gregory J Bedwell
Nature Medicine. 2023-12-01
Journal Articles
- Publisher Correction: Evidence That CD32a Does Not Mark the HIV-1 Latent ReservoirAthe Tsibris, MD, Nature
Press Mentions
- The Rise and Fall of PaxlovidApril 9th, 2024
Grant Support
- Dynamic HIV-1 Escape From CCR5 Antagonism In VitoNational Institute Of Allergy And Infectious Diseases2011
- Dynamic HIV-1 Escape From CCR5 Antagonism In VitoNational Institute Of Allergy And Infectious Diseases2009–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: